Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients

Tian Zhang, Sarabjot Pabla, Felicia L. Lenzo, Jeffrey M. Conroy, Mary K. Nesline, Sean T. Glenn, Antonios Papanicolau-Sengos, Blake Burgher, Vincent Giamo, Jonathan Andreas, Yirong Wang, Wiam Bshara, Katherine G. Madden, Keisuke Shirai, Konstantin Dragnev, Laura J. Tafe, Rajan Gupta, Jason Zhu, Matthew Labriola, Shannon McCallDaniel J. George, Pooja Ghatalia, Farshid Dayyani, Robert Edwards, Michelle S. Park, Rajbir Singh, Robin Jacob, Saby George, Bo Xu, Matthew Zibelman, Razelle Kurzrock, Carl Morrison

Research output: Contribution to journalArticlepeer-review

6 Scopus citations
Original languageEnglish (US)
Article number1773200
JournalOncoImmunology
Volume9
Issue number1
DOIs
StatePublished - Jan 1 2020
Externally publishedYes

Keywords

  • Ki-67
  • Nivolumab
  • PD-1
  • PD-L1
  • proliferation
  • renal cell carcinoma

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology

Cite this